Adaptimmune Therapeutics plc ADAPY
0.02 USD 0.00 (-5.00%)
At closeNov 5, 2026, 4:00 PM EST
0.0171 Day range 0.0189
0.001 52-week range 0.07
- YTD
- -26.92%
- 1 year
- -47.22%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 178.03M | 60.28M | 27.15M | 6.15M | 3.96M | |
| 178.03M | 60.28M | 27.15M | 6.15M | 3.96M | |
| 70.00K | 0 | 0 | 0 | 0 | |
| 177.96M | 60.28M | 27.15M | 6.15M | 3.96M | |
| 246.72M | 200.02M | 191.11M | 168.40M | 137.36M | |
| 149.06M | 126.51M | 127.73M | 111.09M | 91.57M | |
| 87.26M | 73.51M | 63.39M | 57.30M | 45.80M | |
| -68.76M | -139.74M | -163.97M | -162.25M | -133.41M | |
| 3.35M | 0 | 0 | 0 | 0 | |
| 3.58M | 1.34M | 2.50M | 791.00K | 162.00K | |
| -70.81M | -113.87M | -165.46M | -158.09M | -130.09M | |
| -70.81M | -113.87M | -165.46M | -158.09M | -130.09M | |
| -70.81M | -113.87M | -165.46M | -158.09M | -130.09M | |
| -70.81M | -113.87M | -165.46M | -158.09M | -130.09M | |
| -0.30 | -0.54 | -1.02 | -1.02 | -0.90 | |
| -0.30 | -0.54 | -1.02 | -1.02 | -0.90 | |
| -0.30 | -0.54 | -1.02 | -1.02 | -0.90 | |
| -63.89M | -112.53M | -162.96M | -157.30M | -129.93M | |
| -63.89M | -112.53M | -162.96M | -157.30M | -129.93M | |
| 1.51B | 1.21B | 967.24M | 934.83M | 854.78M | |
| 1.51B | 1.21B | 967.24M | 934.83M | 854.78M |